Does Cigna Cover Wegovy in 2026? It Depends on Your Specific Plan

Key Takeaways

• Cigna sometimes covers Wegovy, but coverage depends on the specific employer plan, the formulary tier, and whether the employer has elected the anti-obesity medication (AOM) rider.
• For plans that cover Wegovy, prior authorization is almost always required, with documented BMI thresholds and prior weight-loss attempts.
• Cigna's Express Scripts pharmacy benefit manager subsidiary processes most Wegovy claims; coverage decisions and copay structure flow through Express Scripts.
• Without coverage, Wegovy cash price runs $1,300 to $1,400 per month; the Novo Nordisk Wegovy savings card limits eligible commercial-insurance copays to as low as $0 per fill, with a maximum out-of-pocket of about $650 for uncovered patients.
• The fastest way to verify Cigna coverage of Wegovy is a 5-minute call to the member services number on the back of your Cigna card.

Direct answer (40-60 words)

Cigna sometimes covers Wegovy, but coverage depends on your specific employer plan and whether your plan includes anti-obesity medication benefits. Prior authorization is required on virtually all Cigna plans that cover Wegovy. Verify coverage by calling Cigna member services or checking your plan's formulary on the Cigna or Express Scripts portal.

Table of contents

1. The short answer
2. How Cigna structures pharmacy benefits
3. Plans most likely to cover Wegovy
4. Plans least likely to cover Wegovy
5. Cigna's prior authorization requirements
6. Step therapy and formulary tiers
7. Costs with and without coverage
8. The Wegovy savings card on top of Cigna coverage
9. Appealing a Cigna denial
10. Alternatives if Cigna doesn't cover Wegovy
11. FAQ

The short answer

Cigna isn't a single insurance plan. It's an insurance company that administers thousands of different employer-sponsored and individual plans. Whether your specific Cigna plan covers Wegovy depends on:

• Whether your employer has chosen to include anti-obesity medications (AOMs) in the pharmacy benefit
• Whether Wegovy is on your plan's formulary, and at what tier
• Whether you meet prior-authorization criteria
• Whether your plan applies step therapy (requiring tries of other medications first)

A 5-minute phone call to the number on the back of your Cigna member card resolves these questions for your specific plan. Cigna's automated benefit-check tool also pulls plan-specific coverage if you have an online member account.

How Cigna structures pharmacy benefits

Cigna administers pharmacy benefits through its Express Scripts subsidiary (Cigna acquired Express Scripts in 2018). For practical purposes, this means:

• Your Cigna pharmacy claim is processed by Express Scripts.
• Formulary decisions are made by Cigna/Express Scripts pharmacy and therapeutics committees.
• Prior authorizations are submitted to Express Scripts.
• The mail-order pharmacy is Express Scripts' Accredo specialty pharmacy for many specialty drugs, though Wegovy can typically be filled at retail.

Plan documents usually reference both "Cigna" and "Express Scripts" interchangeably for pharmacy purposes. The member portal lives at myCigna.com, and the pharmacy-specific portal lives at express-scripts.com.

Plans most likely to cover Wegovy

Coverage of anti-obesity medications has grown rapidly across Cigna's book of business since 2023, but it remains employer-by-employer.

Plans most likely to cover Wegovy:

• Large self-funded employer plans with active wellness programs, particularly Fortune 500 employers
• Plans where the employer has signed up for the Cigna anti-obesity rider, which adds Wegovy and similar agents
• Plans that historically cover bariatric surgery (most plans that cover surgery now also cover medications)
• Plans with high preventive-care emphasis, including broad metabolic and cardiovascular benefits

Sectors with strong AOM coverage:

• Technology companies
• Financial services
• Higher education and university systems
• Federal government employees (FEHB program)
• Some state government plans
• Healthcare systems

A 2024 Mercer survey found 44 percent of large employers covered weight-loss medications, up from 22 percent in 2022. Cigna's specific covered population is somewhere in this range.

Plans least likely to cover Wegovy

Plans least likely to cover Wegovy:

• Cigna individual marketplace (Healthcare.gov) plans, which often exclude AOMs entirely
• Small-employer fully insured plans without an AOM rider
• High-deductible health plans (HDHPs) where the deductible exceeds Wegovy's annual cost
• Plans that have explicitly excluded weight-loss medications in plan documents
• Cigna Medicare Advantage plans (Medicare under current law does not cover anti-obesity medications, though some plans add coverage as a supplemental benefit)

If your Cigna plan came through Healthcare.gov, expect a higher chance of denial or non-coverage. Marketplace plans tend to follow narrower formularies.

Cigna's prior authorization requirements

When a Cigna plan covers Wegovy, prior authorization is almost universally required. The standard PA criteria include:

1. BMI thresholds.

• BMI of 30 or higher, or
• BMI of 27 or higher with at least one weight-related comorbid condition (type 2 diabetes, hypertension, hyperlipidemia, sleep apnea, cardiovascular disease)

2. Prior weight-loss attempts.

• Documented participation in a structured weight-management program for at least 3 to 6 months
• Documented intolerance, contraindication, or inadequate response to alternative therapies in some plan designs

3. Provider documentation.

• Prescriber must be in-network or accept Cigna
• Prescription supports the FDA-approved indication (chronic weight management)
• Recent BMI and weight measurements within the prior 6 months

4. Continued-coverage criteria.

• After initial 16 weeks (4 months), the patient must demonstrate at least 5 percent weight loss to continue Wegovy under most Cigna plans.
• Patients who don't meet the 5 percent threshold may have coverage discontinued or be required to discontinue treatment per plan rules.

PA submissions take 3 to 14 days for routine review. Urgent PAs can be processed in 24 to 72 hours when the prescriber documents medical urgency.

Step therapy and formulary tiers

Many Cigna plans apply step therapy, requiring trials of less-expensive medications before approving Wegovy. Common step-therapy requirements include:

• Trial of phentermine (a low-cost generic appetite suppressant) for at least 3 months
• Trial of orlistat (over-the-counter Alli or prescription Xenical)
• Trial of bupropion-naltrexone (Contrave) in some plan designs
• Trial of liraglutide (Saxenda), the older daily-injection GLP-1, in older plan designs

Wegovy typically lands on Tier 3 (non-preferred brand) or Tier 4 (specialty) on covering plans. Copay structure:

Tier	Typical copay structure	Wegovy example
Tier 1 (generic)	$5 to $20	Not applicable
Tier 2 (preferred brand)	$30 to $75	Rare placement
Tier 3 (non-preferred brand)	$75 to $200 or 20-30% coinsurance	Most common
Tier 4 (specialty)	20% to 40% coinsurance, often with monthly cap	Some plans

A patient with Wegovy at Tier 3 with 25 percent coinsurance on a $1,400 list price would owe $350 per month before any savings card.

Costs with and without coverage

With Cigna coverage and prior authorization approved:

• Best case: $25 to $75 copay per fill on plans with strong AOM coverage
• Typical case: $100 to $250 per fill after coinsurance
• Worst case (high-deductible phase): full negotiated rate, around $1,000 to $1,200 per fill, until deductible met

Without Cigna coverage:

• Wegovy cash price: $1,300 to $1,400 per month at major U.S. pharmacies
• With Wegovy savings card: as low as $0 per fill if Cigna covers Wegovy at any copay; up to $650 maximum out-of-pocket if Cigna does not cover Wegovy and the patient pays cash with the card

With Cigna denial and patient appeal:

• During appeal, patient pays cash unless an interim approval is granted
• Typical appeal timeline: 14 to 60 days for a first-level appeal, 30 to 60 additional days for external review

For more on cost optimization, see /articles/comparison-hub/best-glp1-no-insurance.

The Wegovy savings card on top of Cigna coverage

The Novo Nordisk Wegovy savings card is the manufacturer copay assistance program. It can be used with most commercial Cigna plans:

With Cigna coverage of Wegovy:

• Eligible commercial-insurance patients pay as little as $0 per fill, depending on the plan copay
• Maximum benefit covers up to a substantial portion of the copay
• Limited to 13 fills per calendar year per program rules

Without Cigna coverage of Wegovy:

• The card limits cash price to about $650 per fill for eligible patients
• Still substantial but a major improvement over the $1,300 to $1,400 list price
• Some employers have asked PBMs to block manufacturer copay assistance from counting toward deductibles (the "copay accumulator" practice). Cigna plans vary on this.

Eligibility:

• Commercial insurance (any commercial plan, including Cigna)
• Not enrolled in Medicare, Medicaid, TRICARE, VA, or any government-funded plan
• U.S. resident
• Wegovy prescribed for chronic weight management consistent with FDA-approved indication

The card is downloadable from the Novo Nordisk Wegovy website. Bring it to the pharmacy with your Cigna member card.

Appealing a Cigna denial

If Cigna denies Wegovy coverage, you have appeal rights:

Step 1: First-level internal appeal.

• Submit within 180 days of the denial letter
• Provide additional medical documentation: BMI history, prior weight-loss attempts, comorbid conditions, prescriber letter of medical necessity
• Cigna must respond within 30 days for non-urgent appeals, 72 hours for urgent

Step 2: Second-level internal appeal.

• If the first appeal is denied, request second-level review
• Can include a peer-to-peer call between your prescriber and a Cigna medical reviewer
• Same general timeline as first-level appeal

Step 3: External review.

• After internal appeals are exhausted, request external independent review
• An independent third-party reviewer evaluates the case
• External review decisions are binding on Cigna
• Available under federal Affordable Care Act protections for most plans

Documentation that helps an appeal:

• BMI documentation across 6 to 12 months
• Records of prior weight-loss attempts (programs, medications, medical visits)
• Comorbid condition documentation (lab results, sleep study, blood pressure logs)
• A detailed letter of medical necessity from your prescriber addressing each PA criterion
• Cardiovascular risk assessment if applicable

The success rate for Wegovy appeals at the external review level was 38 percent in 2024 across all major insurers per AHIP data, though this varies by case strength.

Alternatives if Cigna doesn't cover Wegovy

If Cigna denies coverage or your plan excludes Wegovy entirely, options include:

1. Wegovy savings card cash pay. About $650 per month for eligible commercial-insurance patients, even without coverage of the medication itself.

2. Compounded semaglutide. State-licensed 503A compounding pharmacies prepare semaglutide in response to individual prescriptions. Prices typically run $150 to $300 per month. FormBlends offers compounded semaglutide starting at $179 per month. See /articles/compounded-and-peptides/compounded-semaglutide-vs-wegovy/ for the comparison.

3. Compounded tirzepatide. Different molecule (tirzepatide), broadly similar weight-loss pathway. Pricing also $150 to $400 per month.

4. Saxenda (liraglutide). An older daily-injection GLP-1 that some Cigna plans cover when Wegovy is excluded. Less effective on average than weekly semaglutide but may be a covered fallback.

5. Other prescription weight-loss medications. Phentermine, orlistat, bupropion-naltrexone, and topiramate-phentermine combinations are often covered when Wegovy is not.

6. Health savings account (HSA) or flexible spending account (FSA). Even without insurance coverage, Wegovy is generally an HSA/FSA-eligible expense, which provides pre-tax savings.

7. Bariatric surgery consultation. For patients with BMI 35 or higher, bariatric surgery is often covered by Cigna plans even when Wegovy isn't. Surgery and medication aren't mutually exclusive.

The right choice depends on your specific benefit, financial situation, and clinical context. A licensed clinician can help map out the options.

FAQ

Does Cigna cover Wegovy in 2026? Sometimes. Coverage depends on the specific Cigna plan, employer rider, and formulary. Many Cigna plans cover Wegovy with prior authorization; others exclude weight-loss medications entirely. Check your plan via myCigna.com or by calling member services.

How do I find out if my Cigna plan covers Wegovy? Call the member services number on the back of your Cigna card and ask whether semaglutide (Wegovy) is on your formulary. Or log into myCigna.com and use the drug-cost estimator. Both methods take under 10 minutes.

What does prior authorization for Wegovy require? Typically a BMI of 30 or higher (or 27 with a weight-related condition), documented prior weight-loss attempts of 3 to 6 months, and a prescription consistent with FDA-approved indications. Specific criteria vary by plan.

How much is the Wegovy copay with Cigna? Ranges widely. Best case is $25 to $75 per fill; typical case is $100 to $250 after coinsurance; high-deductible phase patients pay full price until the deductible is met.

Does Cigna cover Wegovy for weight loss? Wegovy is FDA-approved for chronic weight management, so this is its on-label use. Coverage is for the on-label indication. Off-label uses (like cardiovascular risk reduction outside the approved indication) may require separate prior authorization.

Why did Cigna deny my Wegovy prior authorization? Common reasons: BMI documentation didn't meet thresholds, prior weight-loss program participation wasn't documented, the plan applies step therapy that requires other medications first, or the plan excludes anti-obesity medications entirely.

Can I appeal a Cigna Wegovy denial? Yes. You have the right to internal appeals (typically two levels) and external independent review. The appeal process can take 60 to 120 days total. About 38 percent of Wegovy denials were overturned at external review in 2024.

Does Cigna cover Wegovy through Express Scripts mail order? Many plans allow Wegovy to be filled through Express Scripts mail order with a 90-day supply, often at a lower copay than retail. Some specialty Wegovy fulfillment routes through Accredo. Your plan documents specify which pharmacy network applies.

Does Cigna cover compounded semaglutide as an alternative? Generally no. Cigna and most other commercial insurers don't cover compounded medications. Compounded semaglutide is typically a cash-pay option, often through HSA/FSA accounts.

What's the Wegovy savings card and does it work with Cigna? The Novo Nordisk Wegovy savings card reduces eligible commercial-insurance copays to as little as $0 per fill, with up to a substantial benefit. It works with Cigna commercial plans for patients not enrolled in Medicare, Medicaid, TRICARE, or VA.

Does Cigna Medicare Advantage cover Wegovy? Medicare under current law does not cover anti-obesity medications, including Wegovy. Some Medicare Advantage plans add limited coverage as a supplemental benefit, but most do not. Pending federal legislation could change this.

What if my Cigna plan covers Ozempic but not Wegovy? Ozempic is approved for type 2 diabetes; Wegovy is approved for chronic weight management. Plans frequently cover Ozempic for diabetes patients but exclude Wegovy. Coverage of Ozempic for off-label weight loss is rare. If you have type 2 diabetes, your prescriber may consider Ozempic as a covered alternative.

Sources

1. Novo Nordisk. Wegovy (semaglutide) injection prescribing information. 2024 revision.
2. Cigna. Pharmacy formulary documents. 2026.
3. Express Scripts. National Preferred Formulary. 2026 edition.
4. Mercer. National Survey of Employer-Sponsored Health Plans. 2024.
5. Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384:989-1002.
6. AHIP. Health insurance prior authorization and appeals data. 2024.
7. Centers for Medicare and Medicaid Services. Medicare coverage of obesity treatments. 2026.
8. Affordable Care Act external review process. 45 CFR Part 147.
9. Garvey WT, et al. American Association of Clinical Endocrinology consensus statement on obesity pharmacotherapy. Endocr Pract. 2022;28(7):575-637.
10. Apovian CM, et al. Pharmacological management of obesity: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(2):342-362.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Wegovy, Ozempic, Rybelsus, and Saxenda are registered trademarks of Novo Nordisk A/S. Cigna and Express Scripts are registered trademarks of The Cigna Group and its affiliates. Contrave is a registered trademark of Currax Pharmaceuticals. Alli and Xenical are registered trademarks of GlaxoSmithKline and Roche respectively. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.